ArticleJournal of biomolecular techniques : JBT2026
Shared Resource Management in the Cancer Center Environment: Beyond Operational Excellence.
Article in Journal of biomolecular techniques : JBT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shared Resource Management (SRM) is critical to demonstrating the scientific, operational, and strategic value of shared resources (SRs) within NCI-designated Cancer Centers, particularly during quinquennial Cancer Center Support Grant (CCSG) renewal. SRs provide advanced technologies, specialized expertise, and coordinated infrastructure that support basic, translational, and clinical research. Within this framework, SRM advances three core aims: sustaining state-of-the-art resources, centralizing operational and financial management, and fostering innovation to meet emerging scientific needs. This paper examines SRM through the following aims, highlighting its importance for CCSG preparation, institutional competitiveness, and adaptation to a changing NIH funding landscape. Despite evolving review expectations and funding uncertainty, effective SRM remains essential to cancer center resilience and research excellence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.